NEW MEDICAL CANNABIS BILL
The following gives a brief overiew of the Bill, its impact on patients, and suggestions for change. We will be updating this page regularly so please check back for more information about how the Bill impacts on the health and human rights of patients.
Policy Objectives
The government state its policy objectives are to "create a regulatory framework under which medicinal cannabis products may be prescribed and dispensed in Queensland while also preventing their unauthorised use."
These objectives are limited to prescribing and preventing the unauthorised use of cannabis products that have been cultivated and manufactured in accordance with the Federal governments Narcotic Drugs Act. They fail to include
Achievement of policy objectives
The governemnt propose that the Bill will achieve its policy objectives by creating a regulatory framework with two pathways for patients to be prescribed cannabis treatment.
Alternative ways of achieving policy objectives
The explanatory notes to the Medical Cannabis Bill state there are "no alternative ways of achieving the policy objectives as the use of cannabis needs to be strictly controlled and monitored through legislation in conjunction with the Commonwealth legislation."
There are many reasons why the TGA research trial model does not work for patients. Patients should not have to live their lives being at risk of criminal prosecution or wait for the government to conduct research trials on behalf of overseas companies, especially those patients who are already using cannabis, and benefiting from it. Affordability is another issue for patients, many whom already have the added financial burden of other health care costs, and/or need to rely on disability support pensions or other government incomes.
The following provisions could also be included in the Bill as part of the regulatory framework, and at the same time still achieve the governments policy objectives, or a broader policy objective as mentioned above.
-
Queensland could also establish a register of patients and carers to be approved to cultivate their own cannabis if they have a recommendation from their doctor certifying their medical condition or symptoms suffered from a medical condition, and that the patient has or may benefit from the use of cannabis. The regulations could also include guidelines covering plant limits and security requirements, as outlined in our proposal that was submitted to the government last year. An approval would act as an exemption from criminal charges under the Drugs Misuse Act. If a person acts outside their approval for example selling their cannabis - they will come under the scope of offences in the Drugs Misuse Act.
-
Queensland could establish a state agency to licence the cultivation, manufacture and supply of cannabis within its own state borders if they so chose, as is the case in Victoria.
-
Not for profits could also be given state authorisation to cultivate cannabis for patients who have a recommendation from their doctor certifying that the patient may benefit from the use of cannabis.
-
Queensland could also include exemptions from criminal charges for possesion of small amounts of cannabis for those patients who need to obtain their cannabis from the illicit market.
Bureaucrat: "an official in a government department, in particular one perceived as being concerned with procedural correctness at the expense of people's needs."
Bureaucracy: "excessive multiplication of, and concentration of power in, administrative bureaus or administration characterized by
excessive red tape and routine."
New Bills for Queensland
Public Health (Medicinal Cannabis) Bill 2016: proposes control over patient access to cannabis within the state - controls on prescribing and dispensing. Will repeal current cannabis access provisions in the Health Act and Health (Drugs and Poisons) Regulations.
Medicines, Poisons and Therpaeutic Goods Bill 2015: proposes to adopt the TGA as a law of Queensland. Manufactuers will only need to have TGA licence. Proposes to control patient access to all other medicines through controls on prescribing and dispensing.
* Queensland and WA are the only two states that did not adopt the TGA as a state law. Queensland still has provisions for state manufacturing licences and quality control standards in the Health Act and Health (Drugs and Poisons) Regulation.
Public Health (Medicinal Cannabis) Bill 2016
Patient access does not work in the best interests of the patient now.
The new Medical Cannabis Bill was introduced into the Queensland Parliament on 10 May. This Bill and another Bill the Medicines, Poisons and Therapeutic Goods Bill (proposes to adopt the TGA as a law of QLD) will replace the states Health Act and the Health (Drugs and Poisons) Regulation.
The current State approval process under the Health (Drugs and Poisons) Regulation is indicative of how patient access to cannabis will be controlled in Queensland under the new Bill in the future. We are already bringing to the attention of Queensland Health and the Government a number of issues that are impacting on patient access now, and that need to be resolved as a matter of urgency, regardless of whether the Public Health (Medicinal Cannabis) Bill is passed by Parliament at the end of this year or early next year.
IMG_6253.jpg | QH placards.jpg | 1 day for opiates.jpg |
---|---|---|
Petitioning in the Mall.jpg | Qh Lanai reporter.jpg | Qh Phoenix.jpg |
Taylor.jpg | QH group shot.jpg | Qh protest.jpg |
Qh hazel and kids.jpg | Patients Protest Q Health Building | Medical Cannabis Queensland Hazel and kids.jpg |
Copy of Medical Cannabis Protest and March Brisbane 19 April-4.jpg | Lindsay Scans.jpg |
IMPORTANT POINTS TO REMEMBER
* Once laws are passed by both sides of Parliament they are difficult to change !!
* Regulations under an Act are flexible and can be changed by Cabinet: This was the case in December last year when the Premier and Cabinet had the absolute power to amend the Health (Drugs and Poisons) Regulations removing the long standing prohibition on the use of Schedule 8 and 9 cannabis in the State of Queensland, and made further urgent changes on 1 June ahead of the SUSMP rescheduling of cannabis from Schedule 9 to Schedule 8 which has still not come into effect. These changes mean that patients in Queensland can access medical cannabis ahead of the research trials.
* The Proposed Excessive Powers in the new Act if passed will need an amending Bill to be passed by Parliament if they need to be changed in the future which can take a very long time.
Cannabis: Division of Power between Commonwealth and the States amd Territories
Commonwealth: control import/export under Customs Act and Regulations, and now control the commerical cutlivation and manufacture of cannabis under the Narcotics Drugs Act.
Commonwealth: also control manufacturing licences, standards, advertising, supply, patient access to registered cannabis products, and exemptions fpr patient access to unapproved cannabis via SAS, authorised prescribers, research trials and personal importation under Therapeutic Goods Act.
States and Territories: can control within state borders cultivation, possesion and supply of cannabis by state agencies, criminal offences and defences, and lawful excuse under Drugs Misuse Act, and patient access and supply of cannabis and other medicines under state health laws. In Queensland prescribing and dispensing cannabis and all other medicines currently come under the Health Act and Health (Drugs and Poisons) Regulations. The staes also control the industrial cultivation and manufacture of cannabis,